id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-271896-1ad18z11	Janowitz, Tobias	Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series	2020-06-04		.txt	text/plain	3627	202	47	CONCLUSIONS: The results of this case series suggest that high-dose oral famotidine is well tolerated and associated with improved patient-reported outcomes in non-hospitalised patients with COVID-19. Based on a national institute of health (nih)-endorsed Protocol to research Patient experience of cOViD-19, we collected longitudinal severity scores of five symptoms (cough, shortness of breath, fatigue, headaches and anosmia) and general unwellness on a four-point ordinal scale modelled on performance status scoring. Based on a national institute of health (nih)-endorsed Protocol to research Patient experience of cOViD-19, we collected longitudinal severity scores of five symptoms (cough, shortness of breath, fatigue, headaches and anosmia) and general unwellness on a four-point ordinal scale modelled on performance status scoring. The results of this case series suggest that high-dose oral famotidine is well tolerated and associated with improved patient-reported outcomes in non-hospitalised patients with cOViD-19.	./cache/cord-271896-1ad18z11.txt	./txt/cord-271896-1ad18z11.txt